Skip to content

13F-HR filed by SECTORAL ASSET MANAGEMENT INC

SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 63 holding rows worth $579,649,000.

Accession
0001104659-19-063907
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 63 entries on the cover page, a total value of $579,649,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $579,649,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TELADOC HEALTH INC87918A105COM525,511$35,588,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM3,441,922$27,604,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW432,815$25,527,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM996,983$24,017,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS1,063,872$21,948,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM1,091,534$20,979,000thousands by filing date
SHOCKWAVE MED INC82489T104COM573,434$17,163,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock263,100$16,054,000thousands by filing date
Gilead Sciences,Inc.375558103COM246,940$15,651,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock184,341$14,825,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock546,489$14,657,000thousands by filing date
Bristol-Myers Squibb Company110122108COM280,597$14,229,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock187,750$13,914,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR147,846$12,848,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM377,238$12,758,000thousands by filing date
FIBROGEN INC31572Q808COM333,460$12,331,000thousands by filing date
IMMUNOMEDICS INC452907108COM909,822$12,064,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK478,728$11,801,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM241,040$11,695,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock1,585,752$11,402,000thousands by filing date
ATRICURE INC04963C209COM447,455$11,160,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM451,247$10,672,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM905,247$10,392,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 21,158,271$10,193,000thousands by filing date
Merck & Co.,Inc.58933Y105COM117,600$9,900,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM141,801$9,557,000thousands by filing date
Cigna Corporation125523100COM62,413$9,474,000thousands by filing date
HILL ROM HLDGS INC431475102COM88,099$9,271,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock66,598$9,142,000thousands by filing date
Boston Scientific Corporation101137107COM222,176$9,040,000thousands by filing date
ACCELERON PHARMA INC00434H108COM227,596$8,992,000thousands by filing date
R1 RCM INC749397105COM989,572$8,837,000thousands by filing date
Medtronic PlcG5960L103COM72,651$7,891,000thousands by filing date
Abbott Laboratories002824100COM87,198$7,296,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM719,896$7,077,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM677,759$7,055,000thousands by filing date
TABULA RASA HEALTHCARE INC873379101COMMON STOCK120,600$6,626,000thousands by filing date
Pfizer Inc.717081103COM183,528$6,594,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM84,398$6,357,000thousands by filing date
Eli Lilly and Company532457108COM55,765$6,236,000thousands by filing date
ObsEva SAH5861P103COM643,151$5,357,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM18,200$5,301,000thousands by filing date
FORTY SEVEN INC34983P104COM814,414$5,229,000thousands by filing date
CHANGE HEALTHCARE INC15912K100COM405,750$4,901,000thousands by filing date
EVELO BIOSCIENCES INC299734103COM732,582$4,469,000thousands by filing date
Viewra, Inc92672L107COM1,240,865$3,599,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM36,699$3,594,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK205,306$3,275,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK147,211$2,944,000thousands by filing date
HMS HLDGS CORP40425J101COM77,725$2,679,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM14,171$2,401,000thousands by filing date
COGENT BIOSCIENCES INC COM903214104COM1,519,174$2,188,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM294,615$1,942,000thousands by filing date
SAVARA INC805111101COM710,310$1,882,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK65,063$1,550,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR39,397$1,493,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM10,500$1,473,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM45,400$1,471,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM74,381$1,346,000thousands by filing date
UNIQURE NVN90064101SHS29,500$1,161,000thousands by filing date
SPRING BK PHARMACEUTICALS IN849431101COM276,656$952,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM196,000$817,000thousands by filing date
ALLERGAN PLCG0177J108SHS4,800$808,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-19-063907this filing2019-11-14acceptance time not in the bulk data set